{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=62", "query": { "intervention": "ADM", "page": 62 }, "page_size": 10 }, "pagination": { "page": 62, "page_size": 10, "total_count": 4271, "total_pages": 428, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=63&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ADM&page=61&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-14T15:54:57.660Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06962111", "title": "Early-Stage Partner in Care Living Alone Plus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia", "Mild Cognitive Impairment (MCI)", "Alzheimer Disease" ], "interventions": [ { "name": "Psychoeducational skills training intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Arizona State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 70, "start_date": "2025-03-26", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06962111" }, { "nct_id": "NCT03719430", "title": "APX005M and Doxorubicin in Advanced Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Soft Tissue Sarcoma" ], "interventions": [ { "name": "Doxorubicin", "type": "DRUG" }, { "name": "APX005M", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexander Z. Wei, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2019-03-20", "completion_date": "2025-12-11", "has_results": false, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 3, "location_summary": "Duarte, California • St Louis, Missouri • New York, New York", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03719430" }, { "nct_id": "NCT06325644", "title": "Well-Formulated Ketogenic Diet Polycystic Kidney Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Polycystic Kidney Disease" ], "interventions": [ { "name": "Ketogenic Diet", "type": "OTHER" }, { "name": "Ketone/Glucose Monitoring", "type": "BIOLOGICAL" }, { "name": "CGM/CKM", "type": "BIOLOGICAL" }, { "name": "Blood Draw", "type": "BIOLOGICAL" }, { "name": "Body Composition", "type": "OTHER" }, { "name": "Change in glomerular filtration rate (mg/mmol) via magnetic resonance imaging (MRI) .", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2024-06-01", "completion_date": "2027-04-01", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06325644" }, { "nct_id": "NCT00006034", "title": "Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bladder Cancer" ], "interventions": [ { "name": "keyhole limpet hemocyanin", "type": "BIOLOGICAL" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Intracel", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "1998-06", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2013-05-15", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 1, "location_summary": "Frederick, Maryland", "locations": [ { "city": "Frederick", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006034" }, { "nct_id": "NCT05657119", "title": "Family Safety Net - Aim 3: Randomized Control Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Suicide", "Accidental Injuries", "Firearm Injury" ], "interventions": [ { "name": "MI FSN - Lethal Means Reduction", "type": "BEHAVIORAL" }, { "name": "Scripted FSN - Lethal Means Reduction", "type": "BEHAVIORAL" }, { "name": "General Firearm Safety Intervention - General Firearm Safety", "type": "BEHAVIORAL" }, { "name": "General Firearm Comparison - General Firearm Safety", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2022-11-02", "completion_date": "2025-12-30", "has_results": true, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 1, "location_summary": "Kotzebue, Alaska", "locations": [ { "city": "Kotzebue", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT05657119" }, { "nct_id": "NCT06118346", "title": "A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alcohol Use Disorder", "Risky Health Behavior" ], "interventions": [ { "name": "Female-Specific Cognitive Behavioral Therapy (FS-CBT)", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Massachusetts, Worcester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 162, "start_date": "2023-02-24", "completion_date": "2027-01-30", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06118346" }, { "nct_id": "NCT06268288", "title": "Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postural Tachycardia Syndrome", "Autonomic Dysfunction", "Postural Orthostatic Tachycardia Syndrome", "POTS - Postural Orthostatic Tachycardia Syndrome" ], "interventions": [ { "name": "GammaCore intervention", "type": "DEVICE" }, { "name": "STEPS management protocol", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "12 Years to 19 Years" }, "enrollment_count": 40, "start_date": "2024-02-14", "completion_date": "2024-10-05", "has_results": true, "last_update_posted_date": "2025-10-31", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 2, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06268288" }, { "nct_id": "NCT05864534", "title": "Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Newly Diagnosed Glioblastoma", "Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype", "Gliosarcoma", "Glioblastoma Multiforme" ], "interventions": [ { "name": "Balstilimab", "type": "DRUG" }, { "name": "Botensilimab", "type": "DRUG" }, { "name": "Liposomal Doxorubicin", "type": "DRUG" }, { "name": "Sonocloud-9 (SC-9)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2024-01-19", "completion_date": "2031-08-31", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05864534" }, { "nct_id": "NCT05970042", "title": "Investigating the Effects of the \"GameDay Ready\" Behavioral Weight Management Program for Black Men Living in the Rural South", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "GameDay Ready", "type": "BEHAVIORAL" }, { "name": "Walking and General Health Education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "70 Years", "sex": "MALE", "summary": "20 Years to 70 Years · Male only" }, "enrollment_count": 29, "start_date": "2023-08-04", "completion_date": "2026-06-15", "has_results": false, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 1, "location_summary": "Columbia, South Carolina", "locations": [ { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05970042" }, { "nct_id": "NCT04759586", "title": "Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Primary Mediastinal Large B-Cell Lymphoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin Hydrochloride", "type": "DRUG" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "Etoposide Phosphate", "type": "DRUG" }, { "name": "Filgrastim", "type": "BIOLOGICAL" }, { "name": "Lumbar Puncture", "type": "PROCEDURE" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Pegfilgrastim", "type": "BIOLOGICAL" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Rituximab and Hyaluronidase Human", "type": "BIOLOGICAL" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 244, "start_date": "2021-10-05", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-11-04", "last_synced_at": "2026-11-14T15:54:57.660Z", "location_count": 215, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 162 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04759586" } ] }